Pfizer Stock’s 7% Yield Makes It Look Like a Junk Bond—But Better
In This Article:
Stock market investors have been punishing Pfizer’s stock. Given the stock’s generous 7% yield, maybe junk bond investors should take a look. The venerable drug company, which also developed one of the first Covid-19 vaccines, has seen its share price languish lately.
Terms and Privacy Policy